{"organizations": [], "uuid": "3dc66ccd657cefff813e8ce385df2663a926ed62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-tmunity-therapeutics-raises-100-ml/brief-tmunity-therapeutics-raises-100-mln-in-series-a-financing-to-advance-portfolio-of-t-cell-immunotherapies-idUSASB0C1VC", "country": "US", "domain_rank": 408, "title": "BRIEF-Tmunity Therapeutics Raises $100 Mln In Series A Financing To Advance Portfolio Of T Cell Immunotherapies", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.036, "site_type": "news", "published": "2018-01-23T21:24:00.000+02:00", "replies_count": 0, "uuid": "3dc66ccd657cefff813e8ce385df2663a926ed62"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-tmunity-therapeutics-raises-100-ml/brief-tmunity-therapeutics-raises-100-mln-in-series-a-financing-to-advance-portfolio-of-t-cell-immunotherapies-idUSASB0C1VC", "ord_in_thread": 0, "title": "BRIEF-Tmunity Therapeutics Raises $100 Mln In Series A Financing To Advance Portfolio Of T Cell Immunotherapies", "locations": [], "entities": {"persons": [], "locations": [{"name": "lilly asia ventures", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gilead sciences inc", "sentiment": "none"}, {"name": "olio of next-generation", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) -\n* TMUNITY THERAPEUTICS RAISES $100 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NEXT-GENERATION T CELL IMMUNOTHERAPIES TO TRANSFORM THE TREATMENT OF CANCER\n* TMUNITY THERAPEUTICS - RAISES $100 MILLION IN SERIES A FINANCING, INVESTORS INCLUDE PING AN VENTURES, GILEAD SCIENCES INC, LILLY ASIA VENTURESâ€‹, OTHERS Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T21:24:00.000+02:00", "crawled": "2018-01-24T15:48:43.023+02:00", "highlightTitle": ""}